![]() |
Volumn 125, Issue 6, 2010, Pages
|
Heterogeneity among characteristics of hypereosinophilic syndromes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
BUSULFAN;
CORTICOSTEROID;
CYANOCOBALAMIN;
CYCLOSPORIN;
CYTARABINE;
ETOPOSIDE;
FIP 1 LIKE 1 PROTEIN;
GENE PRODUCT;
HYDROXYUREA;
IMATINIB;
IMMUNOGLOBULIN E;
INTERLEUKIN 4;
INTERLEUKIN 5;
MERCAPTOPURINE;
PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR;
T LYMPHOCYTE RECEPTOR;
TRYPTASE;
UNCLASSIFIED DRUG;
VINCRISTINE;
ADOLESCENT;
ADULT;
AGED;
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION;
BONE MARROW BIOPSY;
CANCER MORTALITY;
CENTRAL NERVOUS SYSTEM DISEASE;
CHILD;
CHROMOSOME ANALYSIS;
CHROMOSOME TRANSLOCATION 17;
CHROMOSOME TRANSLOCATION 6;
CHROMOSOME TRANSLOCATION 7;
COMPUTER ASSISTED TOMOGRAPHY;
CONTROLLED STUDY;
EOSINOPHIL COUNT;
EOSINOPHILIC LEUKEMIA;
FEMALE;
FLOW CYTOMETRY;
GENE REARRANGEMENT;
GENETIC HETEROGENEITY;
HEART FAILURE;
HEPATOMEGALY;
HUMAN;
HYPEREOSINOPHILIC SYNDROME;
KARYOTYPE;
LETTER;
LUNG INFILTRATE;
LYMPHADENOPATHY;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL ASSESSMENT;
NUCLEAR MAGNETIC RESONANCE IMAGING;
POLYMERASE CHAIN REACTION;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
REMISSION;
SCHOOL CHILD;
SPLENOMEGALY;
TREATMENT OUTCOME;
|
EID: 77952745054
PISSN: 00916749
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jaci.2010.02.024 Document Type: Letter |
Times cited : (9)
|
References (7)
|